Furthermore, IGFBP5 may affect the methylation of insulin-like growth factor 1/2, FAM20C, and other molecules, thereby regulating the activation of the PI3K-Akt signaling pathway and facilitating CRC progression.37 The gene discussed is IGFBP5; the disease is colorectal carcinoma.